Figure 1
Figure 1. Using multiparameter flow cytometry, a CD19+CD45low blast cell gating strategy allowed to monitor blast population and HER2-positive expression after trastuzumab infusions. In this example of patient 1, HER2 expression became quasi-undetectable in bone marrow after 12 trastuzumab infusions.

Using multiparameter flow cytometry, a CD19+CD45low blast cell gating strategy allowed to monitor blast population and HER2-positive expression after trastuzumab infusions. In this example of patient 1, HER2 expression became quasi-undetectable in bone marrow after 12 trastuzumab infusions.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal